Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| O-Xylene SCHEMBL5353236 | 0.92 | TSHR (0.50) | TSHRACHECA2ALDH1A1GLA | |
| O-Xylene SCHEMBL9375721 | 0.92 | TSHR (0.50) | TSHRACHECA2ALDH1A1GLA | |
| O-Xylene SCHEMBL16163023 | 0.85 | TSHR (0.48) | TSHRACHECA2ALDH1A1CYP1A2 | |
| O-Xylene SCHEMBL15875994 | 0.82 | TSHR (0.59) | TSHRACHECA2ALDH1A1CA1 | |
| O-Xylene SCHEMBL28730805 | 0.81 | TSHR (0.43) | TSHRACHEALDH1A1HSD17B10MEN1 | |
| SCHEMBL1710090 | 0.81 | TDP1 (0.54) | TSHRALDH1A1GLACYP1A2CYP2C19 | |
| O-Xylene SCHEMBL15875996 | 0.81 | TSHR (0.77) | TSHRACHECA2ALDH1A1CA1 | |
| Toluene SCHEMBL4761329 | 0.80 | TSHR (0.61) | TSHRACHECA2MEN1KMT2A | |
| SCHEMBL4322292 | 0.79 | TSHR (0.48) | TSHRCA2ALDH1A1CA1CA7 | |
| O-Xylene SCHEMBL28002491 | 0.78 | TSHR (0.71) | TSHRACHECA2ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109906239-A | The manufacturing method of oxymethylene copolymer | 三菱瓦斯化学株式会社 | 2019-06-18 | — | — | CN | disclosed |
| CN-105764888-B | A kind of new 3 azabicyclos [3.1.0] hexame derivatives and its medical usage | 株式会社三和化学研究所 | 2018-04-06 | — | — | CN | disclosed |
| CN-107428687-A | Novel crystal of salt of 3-azabicyclo [3.1.0] hexane derivative and medical application thereof | 株式会社三和化学研究所 | 2017-12-01 | — | — | CN | disclosed |
| CN-105339401-B | The manufacture method of oxymethylene copolymer | 三菱瓦斯化学株式会社 | 2017-09-15 | — | — | CN | disclosed |
| CN-105764888-A | Novel 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes | 株式会社三和化学研究所 | 2016-07-13 | — | — | CN | disclosed |
| EP-1724262-B1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-8143274-B2 | 1-(2H)-isoquinolone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20070185160-A1 | 1-(2H)-isoquinolone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1724262-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-11-22 | — | — | EP | disclosed |
| EP-0838537-B1 | METAL SURFACE TREATMENTS, METHOD FOR TREATING METAL SURFACE, AND SURFACE-TREATED METALLIC MATERIAL | NIPPON PAINT CO LTD (JP) | 2001-10-17 | — | — | EP | disclosed |
| EP-0838537-A1 | METAL SURFACE TREATMENTS, METHOD FOR TREATING METAL SURFACE, AND SURFACE-TREATED METALLIC MATERIAL | NIPPON PAINT CO., LTD. (JP) | 1998-04-29 | — | — | EP | disclosed |
| US-4906756-A | 2-(2-nitrovinyl)thiophene reduction and synthesis of thieno[3,2-c]pyridine derivatives | SYNTEX (U.S.A.) INC. (US) | 1990-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185160-A1 | 1-(2H)-isoquinolone derivative | NR3C2, NR1H4, NR3C1 | TSHR 466/4885ACHE 4552/4885CA2 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.